Yu Xin, Li Zheng, Chan Matthew T V, Wu William Ka Kei
Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100042, China.
Department of Orthopaedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100042, China.
Tumour Biol. 2016 Feb;37(2):1445-50. doi: 10.1007/s13277-015-4514-8. Epub 2015 Dec 3.
Wilms' tumor is the most common renal tumor in children in which diffusely anaplastic or unfavorable histology foreshadows poor prognosis. MicroRNAs are small, non-coding RNAs that negatively regulate gene expression at the posttranscriptional level. Accumulating evidence shows that microRNA dysregulation takes part in the pathogenesis of many renal diseases, such as chronic kidney diseases, polycystic kidney disease, renal fibrosis, and renal cancers. In Wilms' tumor, dysregulation of some key oncogenic or tumor-suppressing microRNAs, such as miR-17~92 cluster, miR-185, miR-204, and miR-483, has been documented. In this review, we will summarize current evidence on the role of dysregulated microRNAs in the development of Wilms' tumor.
肾母细胞瘤是儿童最常见的肾肿瘤,其中弥漫性间变性或不良组织学预示着预后不良。微小RNA是小的非编码RNA,在转录后水平负调控基因表达。越来越多的证据表明,微小RNA失调参与了许多肾脏疾病的发病机制,如慢性肾脏病、多囊肾病、肾纤维化和肾癌。在肾母细胞瘤中,一些关键的致癌或抑癌微小RNA,如miR-17~92簇、miR-185、miR-204和miR-483的失调已有文献记载。在本综述中,我们将总结目前关于失调的微小RNA在肾母细胞瘤发生发展中作用的证据。